Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion type Assertion NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_head.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion description "[Similarly, the treatment of primary MALT lymphoma cells with the ABL inhibitors imatinib and dasatinib prevented tumor cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion evidence source_evidence_literature NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion SIO_000772 21454413 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion wasDerivedFrom befree-2016 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion wasGeneratedBy ECO_0000203 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.